Mark Moasser, MD, Professor, Department of Medicine (Hematology/Oncology) at UC San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center. In this video, he speaks about Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers and Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling.
Mark Moasser, MD @UCSF @UCSFCancer #HER2 Resilience And Opportunity In The HER2 Target
